: 93% of participants achieved independence from conventional therapy (active vitamin D and high-dose calcium) by Week 84.
: The treatment was generally well-tolerated with no treatment-related serious or severe adverse events reported through the study period. 2022 05 13 PTh actualizat.rar
If this file is a laboratory or reference update, it likely addresses the ongoing challenges in : 2022 05 13 PTh actualizat.rar
Documents or data files from May 2022 often contain results from the trial, which evaluated TransCon PTH (palopegteriparatide) for adults with hypoparathyroidism. Key findings shared around this time included: 2022 05 13 PTh actualizat.rar